SCHEMBL20161567

SCHEMBL20161567

CC(C)OC(=O)C(CO)C1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PYGB P11216 6/20 0.40
MAPK1 P28482 1/20 0.38
GAA P10253 1/20 0.37
PRKD3 O94806 1/20 0.36
PRKCG P05129 1/20 0.36
PRKCB P05771 1/20 0.36
PRKCA P17252 1/20 0.36
PRKCH P24723 1/20 0.36
PRKCI P41743 1/20 0.36
PRKCE Q02156 1/20 0.36
PRKCQ Q04759 1/20 0.36
PRKCZ Q05513 1/20 0.36
PRKCD Q05655 1/20 0.36
PRKD1 Q15139 1/20 0.36
ALDH1A1 P00352 1/20 0.36
THRB P10828 1/20 0.36
LGALS3 P17931 3/20 0.35
KDR P35968 1/20 0.34
LGALS1 P09382 2/20 0.34
LGALS9 O00182 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20161699 0.85 PYGB (0.42) PYGBMAPK1GAAALDH1A1THRB
SCHEMBL20161566 0.85 PYGB (0.42) PYGBMAPK1GAAALDH1A1THRB
SCHEMBL20161642 0.85 PYGB (0.42) PYGBMAPK1GAAALDH1A1THRB
SCHEMBL20158778 0.84 PYGB (0.41) PYGBMAPK1GAAALDH1A1THRB
SCHEMBL20158782 0.84 PYGB (0.41) PYGBMAPK1GAAALDH1A1THRB
SCHEMBL18214232 0.84 PYGB (0.41) PYGBMAPK1GAAALDH1A1THRB
SCHEMBL20161667 0.79 PYGB (0.38) PYGBMAPK1GAAALDH1A1THRB
SCHEMBL23640046 0.75 LGALS1 (0.47) PYGBGAAALDH1A1THRBLGALS3
SCHEMBL20175904 0.75 LGALS1 (0.47) PYGBGAAALDH1A1THRBLGALS3
SCHEMBL14025369 0.75 LGALS1 (0.47) PYGBGAAALDH1A1THRBLGALS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11045411-B2 Process for treating keratin materials using amide, acid or ester c-glycoside derivatives, and cosmetic composition containing same L'OREAL (FR) 2021-06-29 US disclosed
US-20180133137-A1 PROCESS FOR TREATING KERATIN MATERIALS USING AMIDE, ACID OR ESTER C-GLYCOSIDE DERIVATIVES, AND COSMETIC COMPOSITION CONTAINING SAME L'OREAL (FR) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180133137-A1 PROCESS FOR TREATING KERATIN MATERIALS USING AMIDE, ACID OR ESTER C-GLYCOSIDE DERIVATIVES, AND COSMETIC COMPOSITION CONTAINING SAME KRT18, CUTA, GLA PYGB 3409/4885MAPK1 2735/4885GAA 271/4885
US-11045411-B2 Process for treating keratin materials using amide, acid or ester c-glycoside derivatives, and cosmetic composition containing same KRT18, CUTA, GLA PYGB 3409/4885MAPK1 2735/4885GAA 271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.